1
|
Caignard A, Poupot-Marsan M, Lafont V, Wesch D, Porta C. Editorial: New insights into innate immune cell-based immunotherapies in cancer. Front Immunol 2024; 15:1401665. [PMID: 38655257 PMCID: PMC11035827 DOI: 10.3389/fimmu.2024.1401665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2024] [Accepted: 04/01/2024] [Indexed: 04/26/2024] Open
Affiliation(s)
- Anne Caignard
- Institut National de la Santé et de la Recherche Médicale (INSERM) U1160, Institut de Recherche Saint-Louis Hôpital Saint Louis, Paris, France
| | - Mary Poupot-Marsan
- Centre de Recherche en Cancérologie de Toulouse (CRCT), UMR1037 Institut National de la Santé et de la Recherche Médicale (Inserm)-Univ. Toulouse III Paul Sabatier-ERL5294 Centre National de la Recherche Scientifique (CNRS), 2 avenue Hubert Curien Oncopole de Toulouse, CS53717, Toulouse, France
| | - Virginie Lafont
- Institut de Recherche en Cancérologie de Montpellier (IRCM), Institut National de la Santé et de la Recherche Médicale (INSERM) U1194, Univ Montpellier, Institut du Cancer de Montpellier (ICM), Montpellier, France
| | - Daniela Wesch
- Institute of Immunology, University Medical Center Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany
| | - Chiara Porta
- Department of Pharmaceutical Sciences, University of Eastern Piedmont, Novara, Italy
- Center for Translational Research on Autoimmune & Allergic Diseases (CAAD), University of Eastern Piedmont, Novara, Italy
| |
Collapse
|
2
|
Glasson Y, Chépeaux LA, Dumé AS, Lafont V, Faget J, Bonnefoy N, Michaud HA. Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology. Semin Immunopathol 2023; 45:17-28. [PMID: 36598557 PMCID: PMC9812013 DOI: 10.1007/s00281-022-00978-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2022] [Accepted: 12/11/2022] [Indexed: 01/05/2023]
Abstract
Solid tumors have a dynamic ecosystem in which malignant and non-malignant (endothelial, stromal, and immune) cell types constantly interact. Importantly, the abundance, localization, and functional orientation of each cell component within the tumor microenvironment vary significantly over time and in response to treatment. Such intratumoral heterogeneity influences the tumor course and its sensitivity to treatments. Recently, high-dimensional imaging mass cytometry (IMC) has been developed to explore the tumor ecosystem at the single-cell level. In the last years, several studies demonstrated that IMC is a powerful tool to decipher the tumor complexity. In this review, we summarize the potential of this technology and how it may be useful for cancer research (from preclinical to clinical studies).
Collapse
Affiliation(s)
- Yaël Glasson
- IRCM, Univ Montpellier, ICM, Plateforme de Cytométrie Et d’Imagerie de Masse, Inserm Montpellier, France
| | - Laure-Agnès Chépeaux
- IRCM, Univ Montpellier, ICM, Plateforme de Cytométrie Et d’Imagerie de Masse, Inserm Montpellier, France
| | - Anne-Sophie Dumé
- IRCM, Univ Montpellier, ICM, Plateforme de Cytométrie Et d’Imagerie de Masse, Inserm Montpellier, France
| | | | - Julien Faget
- IRCM, Univ Montpellier, ICM, Inserm Montpellier, France
| | - Nathalie Bonnefoy
- IRCM, Univ Montpellier, ICM, Plateforme de Cytométrie Et d’Imagerie de Masse, Inserm Montpellier, France
| | - Henri-Alexandre Michaud
- IRCM, Univ Montpellier, ICM, Plateforme de Cytométrie Et d'Imagerie de Masse, Inserm Montpellier, France.
| |
Collapse
|
3
|
Lin C, Harner MJ, Douglas AE, Lafont V, Yu F, Lee VG, Poss MA, Swain JF, Wright M, Lipovšek D. Frontispiz: A Selection of Macrocyclic Peptides That Bind STING From an mRNA‐Display Library With Split Degenerate Codons. Angew Chem Int Ed Engl 2021. [DOI: 10.1002/ange.202184261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Chi‐Wang Lin
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| | - Mary J. Harner
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Andrew E. Douglas
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Virginie Lafont
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Fei Yu
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Ving G. Lee
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Michael A. Poss
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | | | - Martin Wright
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| | - Daša Lipovšek
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| |
Collapse
|
4
|
Lin C, Harner MJ, Douglas AE, Lafont V, Yu F, Lee VG, Poss MA, Swain JF, Wright M, Lipovšek D. Frontispiece: A Selection of Macrocyclic Peptides That Bind STING From an mRNA‐Display Library With Split Degenerate Codons. Angew Chem Int Ed Engl 2021. [DOI: 10.1002/anie.202184261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Chi‐Wang Lin
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| | - Mary J. Harner
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Andrew E. Douglas
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Virginie Lafont
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Fei Yu
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Ving G. Lee
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Michael A. Poss
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | | | - Martin Wright
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| | - Daša Lipovšek
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| |
Collapse
|
5
|
Lin C, Harner MJ, Douglas AE, Lafont V, Yu F, Lee VG, Poss MA, Swain JF, Wright M, Lipovšek D. A Selection of Macrocyclic Peptides That Bind STING From an mRNA‐Display Library With Split Degenerate Codons. Angew Chem Int Ed Engl 2021. [DOI: 10.1002/ange.202103043] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Chi‐Wang Lin
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| | - Mary J. Harner
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Andrew E. Douglas
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Virginie Lafont
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Fei Yu
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Ving G. Lee
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | - Michael A. Poss
- Bristol Myers Squibb Route 206 & Province Line Road Lawrenceville NJ 08543 USA
| | | | - Martin Wright
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| | - Daša Lipovšek
- Bristol Myers Squibb 100 Binney Street Cambridge MA 02142 USA
| |
Collapse
|
6
|
Lin CW, Harner MJ, Douglas AE, Lafont V, Yu F, Lee VG, Poss MA, Swain JF, Wright M, Lipovšek D. A Selection of Macrocyclic Peptides That Bind STING From an mRNA-Display Library With Split Degenerate Codons. Angew Chem Int Ed Engl 2021; 60:22640-22645. [PMID: 34383389 PMCID: PMC8518765 DOI: 10.1002/anie.202103043] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Revised: 07/11/2021] [Indexed: 12/05/2022]
Abstract
Recent improvements in mRNA display have enabled the selection of peptides that incorporate non‐natural amino acids, thus expanding the chemical diversity of macrocycles beyond what is accessible in nature. Such libraries have incorporated non‐natural amino acids at the expense of natural amino acids by reassigning their codons. Here we report an alternative approach to expanded amino‐acid diversity that preserves all 19 natural amino acids (no methionine) and adds 6 non‐natural amino acids, resulting in the highest sequence complexity reported to date. We have applied mRNA display to this 25‐letter library to select functional macrocycles that bind human STING, a protein involved in immunoregulation. The resulting STING‐binding peptides include a 9‐mer macrocycle with a dissociation constant (KD) of 3.4 nM, which blocks binding of cGAMP to STING and induces STING dimerization. This approach is generalizable to expanding the amino‐acid alphabet in a library beyond 25 building blocks.
Collapse
Affiliation(s)
- Chi-Wang Lin
- Bristol Myers Squibb, 100 Binney Street, Cambridge, MA, 02142, USA
| | - Mary J Harner
- Bristol Myers Squibb, Route 206 & Province Line Road, Lawrenceville, NJ, 08543, USA
| | - Andrew E Douglas
- Bristol Myers Squibb, Route 206 & Province Line Road, Lawrenceville, NJ, 08543, USA
| | - Virginie Lafont
- Bristol Myers Squibb, Route 206 & Province Line Road, Lawrenceville, NJ, 08543, USA
| | - Fei Yu
- Bristol Myers Squibb, Route 206 & Province Line Road, Lawrenceville, NJ, 08543, USA
| | - Ving G Lee
- Bristol Myers Squibb, Route 206 & Province Line Road, Lawrenceville, NJ, 08543, USA
| | - Michael A Poss
- Bristol Myers Squibb, Route 206 & Province Line Road, Lawrenceville, NJ, 08543, USA
| | | | - Martin Wright
- Bristol Myers Squibb, 100 Binney Street, Cambridge, MA, 02142, USA
| | - Daša Lipovšek
- Bristol Myers Squibb, 100 Binney Street, Cambridge, MA, 02142, USA
| |
Collapse
|
7
|
Lafont V, Lucas S, Bonnefoy N. Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms. Front Immunol 2021; 12:691899. [PMID: 34012459 PMCID: PMC8128245 DOI: 10.3389/fimmu.2021.691899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Accepted: 04/20/2021] [Indexed: 11/13/2022] Open
Affiliation(s)
- Virginie Lafont
- Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Univ Montpellier, Institut du Cancer Montpellier (ICM), Montpellier, France
| | | | - Nathalie Bonnefoy
- Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Univ Montpellier, Institut du Cancer Montpellier (ICM), Montpellier, France
| |
Collapse
|
8
|
Chabab G, Barjon C, Bonnefoy N, Lafont V. Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy. Front Immunol 2020; 11:2186. [PMID: 33042132 PMCID: PMC7524881 DOI: 10.3389/fimmu.2020.02186] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Accepted: 08/11/2020] [Indexed: 12/12/2022] Open
Abstract
The tumor immune microenvironment contributes to tumor initiation, progression and response to therapy. Among the immune cell subsets that play a role in the tumor microenvironment, innate-like T cells that express T cell receptors composed of γ and δ chains (γδ T cells) are of particular interest. Indeed, γδ T cells contribute to the immune response against many cancers, notably through their powerful effector functions that lead to the elimination of tumor cells and the recruitment of other immune cells. However, their presence in the tumor microenvironment has been associated with poor prognosis in various solid cancers (breast, colon and pancreatic cancer), suggesting that γδ T cells also display pro-tumor activities. In this review, we outline the current evidences of γδ T cell pro-tumor functions in human cancer. We also discuss the factors that favor γδ T cell polarization toward a pro-tumoral phenotype, the characteristics and functions of such cells, and the impact of pro-tumor subsets on γδ T cell-based therapies.
Collapse
Affiliation(s)
- Ghita Chabab
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Clément Barjon
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Nathalie Bonnefoy
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Virginie Lafont
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| |
Collapse
|
9
|
Chabab G, Barjon C, Abdellaoui N, Salvador-Prince L, Dejou C, Michaud HA, Boissière-Michot F, Lopez-Crapez E, Jacot W, Pourquier D, Bonnefoy N, Lafont V. Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer. J Leukoc Biol 2020; 107:1057-1067. [PMID: 32362028 DOI: 10.1002/jlb.3ma0420-278rr] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Revised: 04/03/2020] [Accepted: 04/07/2020] [Indexed: 12/27/2022] Open
Abstract
γδ T cells contribute to the immune response against many cancers, notably through their powerful effector functions that lead to the elimination of tumor cells and the recruitment of other immune cells. However, their presence in the tumor microenvironment has been associated with poor prognosis in breast, colon, and pancreatic cancer, suggesting that γδ T cells may also display pro-tumor activities. Here, we identified in blood from healthy donors a subpopulation of Vδ1T cells that represents around 20% of the whole Vδ1 population, expresses CD73, and displays immunosuppressive phenotype and functions (i.e., production of immunosuppressive molecules, such as IL-10, adenosine, and the chemotactic factor IL-8, and inhibition of αβ T cell proliferation). We then found that in human breast tumors, γδ T cells were present particularly in late stage breast cancer samples, and that ∼20% of tumor-infiltrating γδ T cells expressed CD73. Taken together, these results suggest that regulatory γδ T cells are present in the breast cancer microenvironment and may display immunosuppressive functions through the production of immunosuppressive molecules, such as IL-10, IL-8, and adenosine, thus promoting tumor growth.
Collapse
Affiliation(s)
- Ghita Chabab
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Clément Barjon
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France.,Current address: Duve Institute, UCLouvain, Brussels, Belgium
| | - Naoill Abdellaoui
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Lucie Salvador-Prince
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Cécile Dejou
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Henri-Alexandre Michaud
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | | | - Evelyne Lopez-Crapez
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France.,Translational Research Department, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - William Jacot
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France.,Medical Oncology Department, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Didier Pourquier
- Anatomopathology Department, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Nathalie Bonnefoy
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Virginie Lafont
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
| |
Collapse
|
10
|
Abstract
IL-21 is an immunomodulatory cytokine produced by natural killer (NK) cells and T cells that has pleiotropic roles in immune and nonimmune cells. IL-21 can modulate innate and specific immunity activities. It is a potent stimulator of T and natural killer cell-mediated antitumor immunity but also has pro-inflammatory functions in many tissues and is involved in oncogenesis. It is important to understand IL-21 biology in these different situations to ensure the maximal benefit of therapeutic strategies targeting this cytokine. This chapter summarizes IL-21 characteristics and signaling, its role in immune system components, and its use in cancer immunotherapies.
Collapse
Affiliation(s)
- Ghita Chabab
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France
| | - Nathalie Bonnefoy
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France
| | - Virginie Lafont
- IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.
| |
Collapse
|
11
|
|
12
|
Lipovšek D, Carvajal I, Allentoff AJ, Barros A, Brailsford J, Cong Q, Cotter P, Gangwar S, Hollander C, Lafont V, Lau WL, Li W, Moreta M, O'Neil S, Pinckney J, Smith MJ, Su J, Terragni C, Wallace MA, Wang L, Wright M, Marsh HN, Bryson JW. Adnectin-drug conjugates for Glypican-3-specific delivery of a cytotoxic payload to tumors. Protein Eng Des Sel 2018; 31:159-171. [PMID: 30247737 PMCID: PMC6158766 DOI: 10.1093/protein/gzy013] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2018] [Revised: 05/21/2018] [Accepted: 05/30/2018] [Indexed: 12/12/2022] Open
Abstract
Tumor-specific delivery of cytotoxic agents remains a challenge in cancer therapy. Antibody-drug conjugates (ADC) deliver their payloads to tumor cells that overexpress specific tumor-associated antigens-but the multi-day half-life of ADC leads to high exposure even of normal, antigen-free, tissues and thus contributes to dose-limiting toxicity. Here, we present Adnectin-drug conjugates, an alternative platform for tumor-specific delivery of cytotoxic payloads. Due to their small size (10 kDa), renal filtration eliminates Adnectins from the bloodstream within minutes to hours, ensuring low exposure to normal tissues. We used an engineered cysteine to conjugate an Adnectin that binds Glypican-3, a membrane protein overexpressed in hepatocellular carcinoma, to a cytotoxic derivative of tubulysin, with the drug-to-Adnectin ratio of 1. We demonstrate specific, nanomolar binding of this Adnectin-drug conjugate to human and murine Glypican-3; its high thermostability; its localization to target-expressing tumor cells in vitro and in vivo, its fast clearance from normal tissues and its efficacy against Glypican-3-positive mouse xenograft models.
Collapse
Affiliation(s)
- Daša Lipovšek
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - Irvith Carvajal
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | | | - Anthony Barros
- Preclinical Candidate Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA
| | - John Brailsford
- Radiochemistry, Bristol-Myers Squibb, Lawrenceville, NJ, USA
| | - Qiang Cong
- Discovery Chemistry Oncology, Bristol-Myers Squibb, Redwood City, CA, USA
| | - Pete Cotter
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - Sanjeev Gangwar
- Discovery Chemistry Oncology, Bristol-Myers Squibb, Redwood City, CA, USA
| | - Cris Hollander
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - Virginie Lafont
- Molecular Discovery Technologies, Bristol-Myers Squibb, Lawrenceville, NJ, USA
| | - Wai Leung Lau
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - Wenying Li
- Preclinical Candidate Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA
| | - Miguel Moreta
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - Steven O'Neil
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - Jason Pinckney
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - Michael J Smith
- Chemical and Synthetic Development, Bristol-Myers Squibb, New Brunswick, NJ, USA
| | - Julie Su
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - Christina Terragni
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | | | - Lifei Wang
- Preclinical Candidate Optimization, Bristol-Myers Squibb, Lawrenceville, NJ, USA
| | - Martin Wright
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - H Nicholas Marsh
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| | - James W Bryson
- Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, MA, USA
| |
Collapse
|
13
|
Donnelly DJ, Smith RA, Morin P, Lipovšek D, Gokemeijer J, Cohen D, Lafont V, Tran T, Cole EL, Wright M, Kim J, Pena A, Kukral D, Dischino DD, Chow P, Gan J, Adelakun O, Wang XT, Cao K, Leung D, Bonacorsi SJ, Hayes W. Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression. J Nucl Med 2017; 59:529-535. [PMID: 29025984 DOI: 10.2967/jnumed.117.199596] [Citation(s) in RCA: 134] [Impact Index Per Article: 19.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2017] [Accepted: 09/19/2017] [Indexed: 01/20/2023] Open
Abstract
The programmed death protein (PD-1) and its ligand (PD-L1) play critical roles in a checkpoint pathway cancer cells exploit to evade the immune system. A same-day PET imaging agent for measuring PD-L1 status in primary and metastatic lesions could be important for optimizing drug therapy. Herein, we have evaluated the tumor targeting of an anti-PD-L1 adnectin after 18F-fluorine labeling. Methods: An anti-PD-L1 adnectin was labeled with 18F in 2 steps. This synthesis featured fluorination of a novel prosthetic group, followed by a copper-free click conjugation to a modified adnectin to generate 18F-BMS-986192. 18F-BMS-986192 was evaluated in tumors using in vitro autoradiography and PET with mice bearing bilateral PD-L1-negative (PD-L1(-)) and PD-L1-positive (PD-L1(+)) subcutaneous tumors. 18F-BMS-986192 was evaluated for distribution, binding, and radiation dosimetry in a healthy cynomolgus monkey. Results:18F-BMS-986192 bound to human and cynomolgus PD-L1 with a dissociation constant of less than 35 pM, as measured by surface plasmon resonance. This adnectin was labeled with 18F to yield a PET radioligand for assessing PD-L1 expression in vivo. 18F-BMS-986192 bound to tumor tissues as a function of PD-L1 expression determined by immunohistochemistry. Radioligand binding was blocked in a dose-dependent manner. In vivo PET imaging clearly visualized PD-L1 expression in mice implanted with PD-L1(+), L2987 xenograft tumors. Two hours after dosing, a 3.5-fold-higher uptake (2.41 ± 0.29 vs. 0.82 ± 0.11 percentage injected dose per gram, P < 0.0001) was observed in L2987 than in control HT-29 (PD-L1(-)) tumors. Coadministration of 3 mg/kg ADX_5322_A02 anti-PD-L1 adnectin reduced tumor uptake at 2 h after injection by approximately 70%, whereas HT-29 uptake remained unchanged, demonstrating PD-L1-specific binding. Biodistribution in a nonhuman primate showed binding in the PD-L1-rich spleen, with rapid blood clearance through the kidneys and bladder. Binding in the PD-L1(+) spleen was reduced by coadministration of BMS-986192. Dosimetry estimates indicate that the kidney is the dose-limiting organ, with an estimated human absorbed dose of 2.20E-01 mSv/MBq. Conclusion:18F-BMS-986192 demonstrated the feasibility of noninvasively imaging the PD-L1 status of tumors by small-animal PET studies. Clinical studies with 18F-BMS-986192 are under way to measure PD-L1 expression in human tumors.
Collapse
Affiliation(s)
- David J Donnelly
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - R Adam Smith
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Paul Morin
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Daša Lipovšek
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Jochem Gokemeijer
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Daniel Cohen
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Virginie Lafont
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Tritin Tran
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Erin L Cole
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Martin Wright
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Joonyoung Kim
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Adrienne Pena
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Daniel Kukral
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | | | - Patrick Chow
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Jinping Gan
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Olufemi Adelakun
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Xi-Tao Wang
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - Kai Cao
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | - David Leung
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| | | | - Wendy Hayes
- Bristol-Myers Squibb Research and Development, Princeton, New Jersey
| |
Collapse
|
14
|
Barjon C, Michaud HA, Fages A, Dejou C, Zampieri A, They L, Gennetier A, Sanchez F, Gros L, Eliaou JF, Bonnefoy N, Lafont V. IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population. Oncoimmunology 2017; 7:e1379642. [PMID: 29296543 DOI: 10.1080/2162402x.2017.1379642] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Revised: 09/04/2017] [Accepted: 09/10/2017] [Indexed: 10/18/2022] Open
Abstract
Vγ9Vδ2 T cells contribute to the immune response against many tumor types through their direct cytotoxic activity and capacity to regulate the biological functions of other immune cells, such as dendritic cells and IFN-γ-producing CD8+ T cells. However, their presence in the tumor microenvironment has also been associated with poor prognosis in breast, colon and pancreatic cancers. Additionally, recent studies demonstrated that cytokines can confer some plasticity to Vγ9Vδ2 T cells and promote their differentiation into cells with regulatory functions. Here, we demonstrated that activation of Vγ9Vδ2 T cells isolated from healthy donors and cultured in the presence of IL-21 favors the emergence of a subpopulation of Vγ9Vδ2 T cells that express the ectonucleotidase CD73 and inhibits T cell proliferation in a CD73/adenosine-dependent manner. This subpopulation produces IL-10 and IL-8 and displays lower effector functions and cytotoxic activity than CD73-negative Vγ9Vδ2 T cells. We also showed, in a syngeneic mouse tumor model, the existence of a tumor-infiltrating γδ T cell subpopulation that produces IL-10 and strongly expresses CD73. Moreover, maturation, IL-12 production and induction of antigen-specific T cell proliferation are impaired in DC co-cultured with IL-21-amplified Vγ9Vδ2 T cells. Altogether, these data indicate that IL-21 promotes Vγ9Vδ2 T cell regulatory functions by favoring the development of an immunosuppressive CD73+ subpopulation. Thus, when present in the tumor microenvironment, IL-21 might negatively impact γδ T cell anti-tumor functions.
Collapse
Affiliation(s)
- Clément Barjon
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | - Henri-Alexandre Michaud
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | - Angeline Fages
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | | | - Alexandre Zampieri
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | - Laetitia They
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | - Aurélie Gennetier
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | - Françoise Sanchez
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | - Laurent Gros
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | - Jean-François Eliaou
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.,OREGA Biotech, Ecully, France.,Département d'Immunologie, Centre Hospitalier Universitaire de Montpellier et Faculté de Médecine, Université de Montpellier, Hôpital Saint-Eloi, Montpellier cedex 5, France
| | - Nathalie Bonnefoy
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
| | - Virginie Lafont
- Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.,Département d'Immunologie, Centre Hospitalier Universitaire de Montpellier et Faculté de Médecine, Université de Montpellier, Hôpital Saint-Eloi, Montpellier cedex 5, France
| |
Collapse
|
15
|
Cole EL, Kim J, Donnelly DJ, Smith RA, Cohen D, Lafont V, Morin PE, Huang RYC, Chow PL, Hayes W, Bonacorsi S. Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates. Bioorg Med Chem 2017; 25:5407-5414. [PMID: 28803798 DOI: 10.1016/j.bmc.2017.07.066] [Citation(s) in RCA: 64] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2017] [Revised: 07/25/2017] [Accepted: 07/31/2017] [Indexed: 11/30/2022]
Abstract
Cancer immunotherapy, unlike traditional cytotoxic chemotherapeutic treatments, engages the immune system to identify cancer cells and stimulate immune responses. The Programmed Death-1 (PD-1) protein is an immunoinhibitory receptor expressed by activated cytotoxic T-lymphocytes (CTL) that seek out and destroy cancer cells. Multiple cancer types express and upregulate the Programmed Death-Ligand 1 (PD-L1) and 2 (PD-L2) which bind to PD-1 as an immune escape mechanism. Nivolumab is a fully human IgG4 anti-PD-1 monoclonal antibody (mAb) approved for treatment of multiple cancer types. This study reports the preparation and in vivo evaluation of 89Zr labeled nivolumab in healthy non-human primates (NHP) as a preliminary study of biodistribution and clearance. The radiochemical and in vivo stabilities of the 89Zr complex were shown to be acceptable for imaging. Three naïve NHPs were intravenously injected with tracer only or tracer co-injected with nivolumab followed by co-registered by positron emission tomography (PET) and magnetic resonance imaging (MRI), acquired for eight days following injection. Image-derived standardized uptake values (SUV) were quantified by region of interest (ROI) analysis. Radioactivity in the spleen was significantly reduced by addition of excess nivolumab compared to the tracer only study at all imaging time points. Liver uptake of the radiotracer was consistent as a clearance organ with minimal signal from other tissues: lung, muscle, brain, heart, and kidney. The results indicate specific biodistribution to the spleen, which can be blocked by co-administration of excess nivolumab. Distribution to other organs is consistent with elimination pathways of antibodies, with primary clearance through the liver.
Collapse
Affiliation(s)
- Erin L Cole
- Radiochemistry Group, Bristol-Myers Squibb Company, Princeton, NJ, USA.
| | - Joonyoung Kim
- Imaging Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - David J Donnelly
- Radiochemistry Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - R Adam Smith
- Imaging Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Daniel Cohen
- Protein Science Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Virginie Lafont
- Protein Science Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Paul E Morin
- Protein Science Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Richard Y-C Huang
- Bioanalytical and Discovery Analytical Sciences, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Patrick L Chow
- Imaging Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Wendy Hayes
- Imaging Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Samuel Bonacorsi
- Radiochemistry Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| |
Collapse
|
16
|
They L, Michaud HA, Becquart O, Lafont V, Guillot B, Boissière-Michot F, Jarlier M, Mollevi C, Eliaou JF, Bonnefoy N, Gros L. PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody. Oncoimmunology 2017; 6:e1353857. [PMID: 29123966 DOI: 10.1080/2162402x.2017.1353857] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2017] [Revised: 06/27/2017] [Accepted: 06/28/2017] [Indexed: 10/19/2022] Open
Abstract
Tumor antigen-targeting monoclonal antibodies (TA-targeting mAbs) are used as therapeutics in many malignancies and their capacity to mobilize the host immunity puts them at the forefront of anti-cancer immunotherapies. Both innate and adaptive immune cells have been associated with the therapeutic activity of such antibodies, but tumor escape from mAb-induced tumor immune surveillance remains one of the main clinical issues. In this preclinical study, we grafted immunocompetent and immunocompromised mice with the B16F10 mouse melanoma cell line and treated them with the TA99 TA-targeting mAb to analyze the immune mechanisms associated with the tumor response and resistance to TA99 monotherapy. In immunocompetent mice TA99 treatment strongly increased the fraction of CD8 and CD4 effector T cells in the tumor compared with isotype control, highlighting the specific immune modulation of the tumor microenvironment by TA99. However, in most mice, TA99 immunotherapy could not prevent immune effector exhaustion and the recruitment of regulatory CD4 T cells and consequently tumor escape from immune surveillance. Remarkably, anti-PD-1 treatment at the time of tumor emergence restored the Th1 effector functions of CD4 and CD8 T cells as well as of natural killer and γδT cells, which translated into a significant slow-down of tumor progression and extended survival. Our findings provide the first evidence that PD-1 blockade at the time of tumor emergence can efficiently boost the host anti-tumor immune response initiated several weeks before by the TA-targeting mAb. These results are promising for the design of combined therapies to sensitize non-responder or resistant patients.
Collapse
Affiliation(s)
- Laetitia They
- IRCM, Institut de Recherche en Cancérologie de Montpellier; INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Henri-Alexandre Michaud
- IRCM, Institut de Recherche en Cancérologie de Montpellier; INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Ondine Becquart
- IRCM, Institut de Recherche en Cancérologie de Montpellier; INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier, Montpellier, France.,Département de Dermatologie, Centre Hospitalier Universitaire de Montpellier et Faculté de Médecine, Université de Montpellier, Hôpital Saint-Eloi, Montpellier cedex 5, France
| | - Virginie Lafont
- IRCM, Institut de Recherche en Cancérologie de Montpellier; INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Bernard Guillot
- Département de Dermatologie, Centre Hospitalier Universitaire de Montpellier et Faculté de Médecine, Université de Montpellier, Hôpital Saint-Eloi, Montpellier cedex 5, France
| | | | - Marta Jarlier
- Biometrics Unit, Institut Régional du Cancer Montpellier, Montpellier, France
| | - Caroline Mollevi
- Biometrics Unit, Institut Régional du Cancer Montpellier, Montpellier, France
| | - Jean-François Eliaou
- IRCM, Institut de Recherche en Cancérologie de Montpellier; INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier, Montpellier, France.,Département d'Immunologie, Centre Hospitalier Universitaire de Montpellier et Faculté de Médecine, Université de Montpellier, Hôpital Saint-Eloi, Montpellier cedex 5, France
| | - Nathalie Bonnefoy
- IRCM, Institut de Recherche en Cancérologie de Montpellier; INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier, Montpellier, France
| | - Laurent Gros
- IRCM, Institut de Recherche en Cancérologie de Montpellier; INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier, Montpellier, France
| |
Collapse
|
17
|
Bourgeois J, Laye M, Lemaire J, Leone E, Deudon A, Darmon N, Giaume C, Lafont V, Brinck-Jensen S, Dechamps A, König A, Robert P. Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type. J Nutr Health Aging 2016; 20:48-55. [PMID: 26728933 DOI: 10.1007/s12603-016-0675-4] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
This study examined the effectiveness of three different learning methods: trial and error learning (TE), errorless learning (EL) and learning by modeling with spaced retrieval (MR) on the relearning process of IADL in mild-to-moderately severe Alzheimer's Dementia (AD) patients (n=52), using a 6-weeks randomized controlled trial design. The participants had to relearn three IADLs. Repeated-measure analyses during pre-intervention, post-intervention and 1-month delayed sessions were performed. All three learning methods were found to have similar efficiency. However, the intervention produced greater improvements in the actual performance of the IADL tasks than on their explicit knowledge. This study confirms that the relearning of IADL is possible with AD patients through individualized interventions, and that the improvements can be maintained even after the intervention.
Collapse
Affiliation(s)
- J Bourgeois
- J. Bourgeois, COBTEK, EA 7276, Université de Nice Sophia Antipolis, France,
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Ni YG, Yuan X, Newitt JA, Peterson JE, Gleason CR, Haulenbeek J, Santockyte R, Lafont V, Marsilio F, Neely RJ, DeSilva B, Piccoli SP. Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay. AAPS J 2015; 17:976-87. [PMID: 25924887 DOI: 10.1208/s12248-015-9762-4] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/02/2015] [Accepted: 03/25/2015] [Indexed: 01/06/2023]
Abstract
Programmed death-1 (PD-1) protein is a co-inhibitory receptor which negatively regulates immune cell activation and permits tumors to evade normal immune defense. Anti-PD-1 antibodies have been shown to restore immune cell activation and effector function-an exciting breakthrough in cancer immunotherapy. Recent reports have documented a soluble form of PD-1 (sPD-1) in the circulation of normal and disease state individuals. A clinical assay to quantify sPD-1 would contribute to the understanding of sPD-1-function and facilitate the development of anti-PD-1 drugs. Here, we report the development and validation of a sPD-1 protein assay. The assay validation followed the framework for full validation of a biotherapeutic pharmacokinetic assay. A purified recombinant human PD-1 protein was characterized extensively and was identified as the assay reference material which mimics the endogenous analyte in structure and function. The lower limit of quantitation (LLOQ) was determined to be 100 pg/mL, with a dynamic range spanning three logs to 10,000 pg/mL. The intra- and inter-assay imprecision were ≤15%, and the assay bias (percent deviation) was ≤10%. Potential matrix effects were investigated in sera from both normal healthy volunteers and selected cancer patients. Bulk-prepared frozen standards and pre-coated Streptavidin plates were used in the assay to ensure consistency in assay performance over time. This assay appears to specifically measure total sPD-1 protein since the human anti-PD-1 antibody, nivolumab, and the endogenous ligands of PD-1 protein, PDL-1 and PDL-2, do not interfere with the assay.
Collapse
Affiliation(s)
- Yan G Ni
- Bioanalytical Science-Biologics, Bristol-Myers Squibb, L4.016B, Route 206 & Province Line Rd, Princeton, New Jersey, 08543, USA,
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Michaud HA, Eliaou JF, Lafont V, Bonnefoy N, Gros L. Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity. Oncoimmunology 2014; 3:e955684. [PMID: 25941618 DOI: 10.4161/21624011.2014.955684] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2014] [Accepted: 08/04/2014] [Indexed: 01/09/2023] Open
Abstract
Tumor antigen (TA)-targeting monoclonal antibody (mAb)-based treatments are considered to be one of the most successful strategies in cancer therapy. Besides targeting TAs and inducing tumor cell death, such antibodies interact with immune cells through Fc-dependent mechanisms to induce adaptive memory immune responses. However, multiple inhibitory/immunosuppressive pathways can be induced by tumor cells to limit the establishment of an efficient antitumor response and consequently a sustained clinical response to TA-targeting mAbs. Here, we provide an overview on how TA-targeting mAbs in combination with conventional cancer therapies and/or inhibitors of key immunosuppressive pathways might represent promising approaches to achieve long-term tumor control.
Collapse
Key Words
- ADCC, antibody-dependent cell cytotoxicity
- ADCP, antibody-dependent cell phagocytosis
- B-NHL, B-cell non-Hodgkin's lymphoma
- CDC, complement-dependent cytotoxicity
- CTLA4, cytotoxic T-lymphocyte-associated protein 4
- DC, dendritic cell
- FDA, food and drug administration
- FcRn, neonatal Fc receptor
- HMGB1, high-mobility group box 1
- ICD, immunologic cell death
- IDO, indoleamine 2, 3-dioxygenase
- IFNγ, interferon γ
- MDSC, myeloid-derived suppressor cell
- NK, natural killer
- PD-1, programmed cell death 1
- TA, tumor antigen
- TA-targeting mAbs
- Treg, regulatory T cell
- combined therapies
- immunomodulation
- immunosuppressive pathways
- mAb, monoclonal antibody
- vaccine-like effects
Collapse
Affiliation(s)
- Henri-Alexandre Michaud
- Institut de Recherche en Cancérologie de Montpellier; Inserm U896 ; Institut Régional de Lutte contre le Cancer (ICM); Université Montpellier 1 ; Montpellier Cedex, France
| | - Jean-François Eliaou
- Institut de Recherche en Cancérologie de Montpellier; Inserm U896 ; Institut Régional de Lutte contre le Cancer (ICM); Université Montpellier 1 ; Montpellier Cedex, France ; Département d'Immunologie; CHRU Montpellier and Faculté de Médecine; Université Montpellier I ; Montpellier Cedex, France
| | - Virginie Lafont
- Institut de Recherche en Cancérologie de Montpellier; Inserm U896 ; Institut Régional de Lutte contre le Cancer (ICM); Université Montpellier 1 ; Montpellier Cedex, France
| | - Nathalie Bonnefoy
- Institut de Recherche en Cancérologie de Montpellier; Inserm U896 ; Institut Régional de Lutte contre le Cancer (ICM); Université Montpellier 1 ; Montpellier Cedex, France ; co-senior authors
| | - Laurent Gros
- Institut de Recherche en Cancérologie de Montpellier; Inserm U896 ; Institut Régional de Lutte contre le Cancer (ICM); Université Montpellier 1 ; Montpellier Cedex, France ; co-senior authors
| |
Collapse
|
20
|
Lafont V, Sanchez F, Laprevotte E, Michaud HA, Gros L, Eliaou JF, Bonnefoy N. Plasticity of γδ T Cells: Impact on the Anti-Tumor Response. Front Immunol 2014; 5:622. [PMID: 25538706 PMCID: PMC4259167 DOI: 10.3389/fimmu.2014.00622] [Citation(s) in RCA: 88] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2014] [Accepted: 11/21/2014] [Indexed: 01/17/2023] Open
Abstract
The tumor immune microenvironment contributes to tumor initiation, progression, and response to therapy. Among the immune cell subsets that play a role in the tumor microenvironment, innate-like T cells that express T cell receptors composed of γ and δ chains (γδ T cells) are of particular interest. γδ T cells can contribute to the immune response against many tumor types (lymphoma, myeloma, melanoma, breast, colon, lung, ovary, and prostate cancer) directly through their cytotoxic activity and indirectly by stimulating or regulating the biological functions of other cell types required for the initiation and establishment of the anti-tumor immune response, such as dendritic cells and cytotoxic CD8+ T cells. However, the notion that tumor-infiltrating γδ T cells are a good prognostic marker in cancer was recently challenged by studies showing that the presence of these cells in the tumor microenvironment was associated with poor prognosis in both breast and colon cancer. These findings suggest that γδ T cells may also display pro-tumor activities. Indeed, breast tumor-infiltrating γδ T cells could exert an immunosuppressive activity by negatively regulating dendritic cell maturation. Furthermore, recent studies demonstrated that signals from the microenvironment, particularly cytokines, can confer some plasticity to γδ T cells and promote their differentiation into γδ T cells with regulatory functions. This review focuses on the current knowledge on the functional plasticity of γδ T cells and its effect on their anti-tumor activities. It also discusses the putative mechanisms underlying γδ T cell expansion, differentiation, and recruitment in the tumor microenvironment.
Collapse
Affiliation(s)
- Virginie Lafont
- U896, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM , Montpellier , France ; Centre Régional de Lutte Contre le Cancer CRLC Val d'Aurelle - Paul Lamarque, Université Montpellier 1 , Montpellier , France
| | - Françoise Sanchez
- U896, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM , Montpellier , France ; Centre Régional de Lutte Contre le Cancer CRLC Val d'Aurelle - Paul Lamarque, Université Montpellier 1 , Montpellier , France
| | - Emilie Laprevotte
- U896, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM , Montpellier , France ; Centre Régional de Lutte Contre le Cancer CRLC Val d'Aurelle - Paul Lamarque, Université Montpellier 1 , Montpellier , France
| | - Henri-Alexandre Michaud
- U896, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM , Montpellier , France ; Centre Régional de Lutte Contre le Cancer CRLC Val d'Aurelle - Paul Lamarque, Université Montpellier 1 , Montpellier , France
| | - Laurent Gros
- U896, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM , Montpellier , France ; Centre Régional de Lutte Contre le Cancer CRLC Val d'Aurelle - Paul Lamarque, Université Montpellier 1 , Montpellier , France
| | - Jean-François Eliaou
- U896, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM , Montpellier , France ; Centre Régional de Lutte Contre le Cancer CRLC Val d'Aurelle - Paul Lamarque, Université Montpellier 1 , Montpellier , France ; Département d'Immunologie, Centre Hospitalier Régional Universitaire de Montpellier et Faculté de Médecine, Université Montpellier 1 , Montpellier , France
| | - Nathalie Bonnefoy
- U896, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM , Montpellier , France ; Centre Régional de Lutte Contre le Cancer CRLC Val d'Aurelle - Paul Lamarque, Université Montpellier 1 , Montpellier , France
| |
Collapse
|
21
|
Bessoles S, Ni M, Garcia-Jimenez S, Sanchez F, Lafont V. Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteria. Eur J Immunol 2011; 41:1619-28. [DOI: 10.1002/eji.201041230] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2010] [Revised: 02/28/2011] [Accepted: 03/21/2011] [Indexed: 11/11/2022]
|
22
|
Jiménez de Bagüés M, Ouahrani‐Bettache S, Quintana J, Mitjana O, Hanna N, Bessoles S, Sanchez F, Scholz H, Lafont V, Köhler S, Occhialini A. The New SpeciesBrucella microtiReplicates in Macrophages and Causes Death in Murine Models of Infection. J Infect Dis 2010; 202:3-10. [DOI: 10.1086/653084] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
23
|
Abstract
Binding affinity optimization is critical during drug development. Here, we evaluate the thermodynamic consequences of filling a binding cavity with functionalities of increasing van der Waals radii (-H, -F, -Cl, and CH(3)) that improve the geometric fit without participating in hydrogen bonding or other specific interactions. We observe a binding affinity increase of two orders of magnitude. There appears to be three phases in the process. The first phase is associated with the formation of stable van der Waals interactions. This phase is characterized by a gain in binding enthalpy and a loss in binding entropy, attributed to a loss of conformational degrees of freedom. For the specific case presented in this article, the enthalpy gain amounts to -1.5 kcal/mol while the entropic losses amount to +0.9 kcal/mol resulting in a net 3.5-fold affinity gain. The second phase is characterized by simultaneous enthalpic and entropic gains. This phase improves the binding affinity 25-fold. The third phase represents the collapse of the trend and is triggered by the introduction of chemical functionalities larger than the binding cavity itself [CH(CH(3))(2)]. It is characterized by large enthalpy and affinity losses. The thermodynamic signatures associated with each phase provide guidelines for lead optimization.
Collapse
Affiliation(s)
- Yuko Kawasaki
- Department of Biology, Johns Hopkins University, Baltimore MD 21218
| | - Eduardo E. Chufan
- Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21205
| | - Virginie Lafont
- Department of Biology, Johns Hopkins University, Baltimore MD 21218
| | - Koushi Hidaka
- Department of Medicinal Chemistry, Center for Frontier Research in Medicinal Science, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan
| | - Yoshiaki Kiso
- Department of Medicinal Chemistry, Center for Frontier Research in Medicinal Science, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan
| | - L. Mario Amzel
- Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21205
| | - Ernesto Freire
- Department of Biology, Johns Hopkins University, Baltimore MD 21218
,Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21205
,Corresponding author: Department of Biology, The Johns Hopkins University, 3400 North Charles, Baltimore, MD 21218; Phone: (410) 516-7743, Fax: (410) 516-6469;
| |
Collapse
|
24
|
Espert L, Varbanov M, Robert-Hebmann V, Sagnier S, Robbins I, Sanchez F, Lafont V, Biard-Piechaczyk M. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 2009; 4:e5787. [PMID: 19492063 PMCID: PMC2686268 DOI: 10.1371/journal.pone.0005787] [Citation(s) in RCA: 107] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2008] [Accepted: 05/05/2009] [Indexed: 11/22/2022] Open
Abstract
Background HIV-1 can infect and replicate in both CD4 T cells and macrophages. In these cell types, HIV-1 entry is mediated by the binding of envelope glycoproteins (gp120 and gp41, Env) to the receptor CD4 and a coreceptor, principally CCR5 or CXCR4, depending on the viral strain (R5 or X4, respectively). Uninfected CD4 T cells undergo X4 Env-mediated autophagy, leading to their apoptosis, a mechanism now recognized as central to immunodeficiency. Methodology/Principal Findings We demonstrate here that autophagy and cell death are also induced in the uninfected CD4 T cells by HIV-1 R5 Env, while autophagy is inhibited in productively X4 or R5-infected CD4 T cells. In contrast, uninfected macrophages, a preserved cell population during HIV-1 infection, do not undergo X4 or R5 Env-mediated autophagy. Autophagosomes, however, are present in macrophages exposed to infectious HIV-1 particles, independently of coreceptor use. Interestingly, we observed two populations of autophagic cells: one highly autophagic and the other weakly autophagic. Surprisingly, viruses could be detected in the weakly autophagic cells but not in the highly autophagic cells. In addition, we show that the triggering of autophagy in macrophages is necessary for viral replication but addition of Bafilomycin A1, which blocks the final stages of autophagy, strongly increases productive infection. Conclusions/Significance Taken together, our data suggest that autophagy plays a complex, but essential, role in HIV pathology by regulating both viral replication and the fate of the target cells.
Collapse
Affiliation(s)
- Lucile Espert
- CPBS, UM1, UM2, CNRS, Institut de Biologie, 4, CS 69033, Montpellier, France
| | - Mihayl Varbanov
- CPBS, UM1, UM2, CNRS, Institut de Biologie, 4, CS 69033, Montpellier, France
| | | | - Sophie Sagnier
- CPBS, UM1, UM2, CNRS, Institut de Biologie, 4, CS 69033, Montpellier, France
| | - Ian Robbins
- Institut de génétique Moléculaire, Montpellier, France
| | - Françoise Sanchez
- CPBS, UM1, UM2, CNRS, Institut de Biologie, 4, CS 69033, Montpellier, France
| | - Virginie Lafont
- CPBS, UM1, UM2, CNRS, Institut de Biologie, 4, CS 69033, Montpellier, France
| | | |
Collapse
|
25
|
Bessoles S, Dudal S, Besra GS, Sanchez F, Lafont V. Human CD4+invariant NKT cells are involved in antibacterial immunity againstBrucella suisthrough CD1d-dependent but CD4-independent mechanisms. Eur J Immunol 2009; 39:1025-35. [DOI: 10.1002/eji.200838929] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
26
|
Bouhet S, Lafont V, Billard E, Gross A, Dornand J. The IFNgamma-induced STAT1-CBP/P300 association, required for a normal response to the cytokine, is disrupted in Brucella-infected macrophages. Microb Pathog 2008; 46:88-97. [PMID: 19041714 DOI: 10.1016/j.micpath.2008.10.011] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2008] [Revised: 10/24/2008] [Accepted: 10/31/2008] [Indexed: 01/18/2023]
Abstract
To develop intracellularly within phagocytes and cause chronic infection, Brucella must overcome different steps of the host immune responses. IFNgamma is a key mediator of the innate and adaptive responses produced during Brucella infection. Therefore, Brucella would control host defenses by impairing macrophage responses to IFNgamma. We first showed that in infected human macrophages (VD3-differentiated THP-1 cells) Brucella escaped the microbicidal environment generated by IFNgamma. We then analyzed the IFNgamma-mediated signaling in Brucella-infected cells. We observed no decrease in STAT1 tyrosine or serine phosphorylation, or in dimerization of phosphorylated STAT1 (P-STAT1) and P-STAT1 translocation to the nucleus or in P-STAT1 binding to GAS, a minimal IFNgamma-response DNA sequence. In contrast, immuno-precipitation experiments indicated that the IFNgamma-mediated association of P-STAT1 with CBP/P300 transactivators was markedly reduced in infected macrophages, demonstrating that P-STAT1 was unable to normally recruit these transactivators. The host cell cAMP pathway triggered by Brucella could be responsible for this defect, CBP/P300 mobilization by phosphorylated CREB (P-CREB) disrupting the IFNgamma-induced STAT1-CBP/P300 association, required for a normal response of macrophages to IFNgamma. In any case, the inhibition of an essential protein-protein interaction probably lead to a deteriorated response to IFNgamma and thus participated in the pathogen's establishment within its host.
Collapse
Affiliation(s)
- Sandrine Bouhet
- Université Montpellier1, Centre d'étude d'Agents Pathogènes et Biotechnologies pour la Santé (CPBS), France
| | | | | | | | | |
Collapse
|
27
|
Bessoles S, Fouret F, Dudal S, Besra GS, Sanchez F, Lafont V. IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines. J Leukoc Biol 2008; 84:224-33. [PMID: 18456817 DOI: 10.1189/jlb.1007669] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
NKT cells belong to a conserved T lymphocyte subgroup that has been implicated in the regulation of various immune responses, including responses to viruses, bacteria, and parasites. They express a semi-invariant TCR that recognizes glycolipids presented by the nonpolymorphic MHC class I-like molecule CD1d, and upon activation, they produce various pro- and anti-inflammatory cytokines. Recent studies have shed light on the nature of glycolipids and the environmental signals that may influence the production of cytokines by NKT cells and thus, modulate the immune response. To better understand the regulation mechanisms of NKT cells, we explored their behavior following activation by IL-2 and investigated the signaling pathways and biological responses triggered. We demonstrated that IL-2 activates not only STAT3 and -5 and the PI-3K and ERK-2 pathways as in all IL-2 responder cells but also STAT4 as in NK cells and the p38 MAPK pathway as in alphabeta T cells. We also showed that STAT6 is activated by IL-2 in NKT cells. Moreover, IL-2 induces the production of IFN-gamma and IL-4. The ability of IL-2 to induce pro- and anti-inflammatory cytokine production, in addition to proliferation, could open new therapeutic approaches for use in combination with molecules that activate NKT cells through TCR activation.
Collapse
Affiliation(s)
- Stéphanie Bessoles
- Université Montpellier I, Centre d'étude d'agents Pathogènes et Biotechnologies pour la Santé, CNRS UMR 5236, Montpellier, France
| | | | | | | | | | | |
Collapse
|
28
|
Liautard J, Ouahrani-Bettache S, Jubier-Maurin V, Lafont V, Köhler S, Liautard JP. Identification and isolation of Brucella suis virulence genes involved in resistance to the human innate immune system. Infect Immun 2007; 75:5167-74. [PMID: 17709411 PMCID: PMC2168268 DOI: 10.1128/iai.00690-07] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Brucella strains are facultative intracellular pathogens that induce chronic diseases in humans and animals. This observation implies that Brucella subverts innate and specific immune responses of the host to develop its full virulence. Deciphering the genes involved in the subversion of the immune system is of primary importance for understanding the virulence of the bacteria, for understanding the pathogenic consequences of infection, and for designing an efficient vaccine. We have developed an in vitro system involving human macrophages infected by Brucella suis and activated syngeneic gamma9delta2 T lymphocytes. Under these conditions, multiplication of B. suis inside macrophages is only slightly reduced. To identify the genes responsible for this reduced sensitivity, we screened a library of 2,000 clones of transposon-mutated B. suis. For rapid and quantitative analysis of the multiplication of the bacteria, we describe a simple method based on Alamar blue reduction, which is compatible with screening a large library. By comparing multiplication inside macrophages alone and multiplication inside macrophages with activated gamma9delta2 T cells, we identified four genes of B. suis that were necessary to resist to the action of the gamma9delta2 T cells. The putative functions of these genes are discussed in order to propose possible explanations for understanding their exact role in the subversion of innate immunity.
Collapse
Affiliation(s)
- Janny Liautard
- CNRS-UMR 5236 and Université Montpellier II, CC100, place Eugène Bataillon, 34000 Montpellier, France.
| | | | | | | | | | | |
Collapse
|
29
|
Abstract
A common strategy to improve the potency of drug candidates is to introduce chemical functionalities, like hydrogen bond donors or acceptors, at positions where they are able to establish strong interactions with the target. However, it is often observed that the added functionalities do not necessarily improve potency even if they form strong hydrogen bonds. Here, we explore the thermodynamic and structural basis for those observations. KNI-10033 is a potent experimental HIV-1 protease inhibitor with picomolar affinity against the wild-type enzyme (K(d) = 13 pm). The potency of the inhibitor is the result of favorable enthalpic (DeltaH = -8.2 kcal/mol) and entropic (-TDeltaS = -6.7 kcal/mol) interactions. The replacement of the thioether group in KNI-10033 by a sulfonyl group (KNI-10075) results in a strong hydrogen bond with the amide of Asp 30B of the HIV-1 protease. This additional hydrogen bond improves the binding enthalpy by 3.9 kcal/mol; however, the enthalpy gain is completely compensated by an entropy loss, resulting in no affinity change. Crystallographic and thermodynamic analysis of the inhibitor/protease complexes indicates that the entropy losses are due to a combination of conformational and solvation effects. These results provide a set of practical guidelines aimed at overcoming enthalpy/entropy compensation and improve binding potency.
Collapse
Affiliation(s)
- Virginie Lafont
- Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA
| | | | | | | | | | | |
Collapse
|
30
|
Lafont V, Schaefer M, Stote RH, Altschuh D, Dejaegere A. Protein-protein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies "efficient amino acids". Proteins 2007; 67:418-34. [PMID: 17256770 DOI: 10.1002/prot.21259] [Citation(s) in RCA: 79] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
The molecular mechanics Poisson-Boltzmann surface area (MM/PBSA) method was applied to the study of the protein-protein complex between a camelid single chain variable domain (cAb-Lys3) and hen egg white lysozyme (HEL), and between cAb-Lys3 and turkey egg white lysozyme (TEL). The electrostatic energy was estimated by solving the linear Poisson-Boltzmann equation. A free energy decomposition scheme was developed to determine binding energy hot spots of each complex. The calculations identified amino acids of the antibody that make important contributions to the interaction with lysozyme. They further showed the influence of small structural variations on the energetics of binding and they showed that the antibody amino acids that make up the hot spots are organized in such a way as to mimic the lysozyme substrate. Through further analysis of the results, we define the concept of "efficient amino acids," which can provide an assessment of the binding potential of a particular hot spot interaction. This information, in turn, can be useful in the rational design of small molecules that mimic the antibody. The implications of using free energy decomposition to identify regions of a protein-protein complex that could be targeted by small molecules inhibitors are discussed.
Collapse
Affiliation(s)
- Virginie Lafont
- Structural Biology and Genomics Department, UMR 7104, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS / INSERM / ULP, F-67404 Illkirch Cedex, France
| | | | | | | | | |
Collapse
|
31
|
Dudal S, Turriere C, Bessoles S, Fontes P, Sanchez F, Liautard J, Liautard JP, Lafont V. Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis. J Immunol 2007; 177:5533-9. [PMID: 17015740 DOI: 10.4049/jimmunol.177.8.5533] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Human Vgamma9Vdelta2 T cells play a crucial role in early immune response to intracellular pathogens. Moreover, in brucellosis, these cells are drastically increased in the peripheral blood of patients during the acute phase of infection. In vitro, Vgamma9Vdelta2 T cells are capable of inhibiting Brucella growth and development through a combination of mechanisms: 1) cytotoxicity, 2) macrophage activation and bactericidal activity through cytokine and chemokine secretion, and 3) antibacterial effects. We previously described that antibacterial factors were found in supernatants from activated Vgamma9Vdelta2 T cells. In this study, we show that Vgamma9Vdelta2 T cells express the human cathelicidin hCAP18 and its mature form, known as LL-37, is released upon activation of Vgamma9Vdelta2 T cells. We also show that LL-37 has an antibacterial effect on Brucella suis. Overall, our results demonstrate that LL-37 is a soluble factor responsible for a part of the bactericidal activity of Vgamma9Vdelta2 T cells.
Collapse
Affiliation(s)
- Sherri Dudal
- Institut National de la Santé et de la Recherche Médicale, Unité 431, Université Montpellier 2, Montpellier, France
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Morjaria S, Deleuze-Masquefa C, Lafont V, Gayraud S, Bompart J, Bonnet PA, Dornand J. Impairment of TNF-alpha production and action by imidazo[1,2- alpha] quinoxalines, a derivative family which displays potential anti-inflammatory properties. Int J Immunopathol Pharmacol 2006; 19:525-38. [PMID: 17026837 DOI: 10.1177/039463200601900308] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
In a previous study, we analysed the synthesis and properties of a series of imidazo[1,2-alpha]quinoxalines designed in our laboratory as possible imiquimod analogues. We found that these imidazo[1,2-alpha]quinoxalines were in fact potent inhibitors of phosphodiesterase 4 enzymes (PDE4). PDE4 inhibition normally results in an increase in intracellular cAMP which, in PBMC, induces the suppression of TNF-alpha mRNA transcription and thus cytokine synthesis. Such an effect is antagonistic to that of imiquimod. Furthermore, some TNF-alpha-induced activity, such as cell apoptosis which is dependent on the intracellular cAMP levels might also be affected. Therefore, by counteracting the properties of TNF-alpha and/or its production, the imidazo[1,2-alpha]quinoxalines could be considered as potential anti-inflammatory drugs. The present study was performed to confirm or refute this hypothesis. For this, we characterized the effects of imidazo[1,2-alpha]quinoxalines both on TNF-alpha activity and synthesis in regard to their ability to act as inhibitors of PDE4 (IPDE4). We found that the imidazo[1,2-alpha]quinoxalines dose-dependently prevented the TNF-alpha-triggered death of L929 cells, with the 8-series (-NHCH3 in R4) being the most potent. Moreover, when the effect of the 8-series on TNF-alpha production was investigated using gamma9delta2 T cells, it was observed that these compounds impaired the TCR:CD3-triggered TNF-alpha production. Structure-activity analysis revealed that these properties of the drugs did not coincide with their IPDE4 properties. This prompted further exploration into other signalling mechanisms possibly involved in TNF-alpha action and production, notably the p38 MAPK and the PI3K pathway. We demonstrate here that the imidazo[1,2-alpha]quinoxalines targeted these pathways in a different way: they activated the p38 MAPK pathway whilst inhibiting the PI3K pathway. Such effects on cell signalling could account for the imidazo[1,2-alpha]quinoxalines effects on 1) action and 2) production of TNF-alpha, which define these drugs as potential anti-inflammatory agents.
Collapse
Affiliation(s)
- S Morjaria
- INSERM U431, University of Montpellier, France
| | | | | | | | | | | | | |
Collapse
|
33
|
Lafont V, Leach L, Proulx G, Bertogliati C, Michel E, Clairet S, Baudu C, Averbeke H, Benoit M, Robert P. P3-22 Exploration de la mémoire épisodique par la Kaplan Baycrest Neurocognitive Assessment (KBNA) : comparaison de 4 populations : sujets témoins (TEM), plaintes mnésiques (PLAI), troubles cognitifs légers (MCI), maladies d’Alzheimer (MA). Rev Neurol (Paris) 2005. [DOI: 10.1016/s0035-3787(05)85387-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
Delmonte M, Sadaillan L, Michel E, Lafont V, Bertogliati C, Baudu C, Robert P. P2-25 Évaluation des centres d’intérêts. Rev Neurol (Paris) 2005. [DOI: 10.1016/s0035-3787(05)85353-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
35
|
Benoit M, Bertogliati C, Boulhassas R, Lechowski L, Brocker P, Guerin O, Bedoucha P, Lafont V, Robert P. P2-16 Caractéristiques des patients avec et sans traitement antipsychotique dans la cohorte PHRC-REAL. Rev Neurol (Paris) 2005. [DOI: 10.1016/s0035-3787(05)85344-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
36
|
Robert P, Michel E, Benoit M, Lafont V, Baudu C, Bertogliati C, Goni S. P3-33 Validation du NPI-R, version réduite de l’Inventaire Neuropsychiatrique français. Rev Neurol (Paris) 2005. [DOI: 10.1016/s0035-3787(05)85398-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
37
|
Dejaegere A, Choulier L, Lafont V, De Genst E, Altschuh D. Variations in Antigen−Antibody Association Kinetics as a Function of pH and Salt Concentration: A QSAR and Molecular Modeling Study. Biochemistry 2005; 44:14409-18. [PMID: 16262241 DOI: 10.1021/bi050986v] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The relationship between three environmental factors (ionic strength, pH, and temperature) and antigen-antibody binding kinetics was investigated using QSAR (quantitative structure-activity relationship) and molecular modeling approaches. The interaction used for this analysis is that between the camel antibody fragment cAbLys3 and lysozyme. Binding kinetics were measured using a Biacore 2000 instrument, at NaCl concentrations between 50 and 500 mM, at pH's between 5 and 10, and at temperatures between 15 and 30 degrees C, according to multivariate experimental designs. Variations in kinetic on- and off-rate parameters were up to 400- and 16-fold, respectively. Mathematical models that relate log k(on) to experimental conditions were developed. They indicated an influence of all three factors, with a clear dependency between pH and NaCl concentration for their effect on k(on). These models were able to predict on-rate parameters under new experimental conditions. Titration calculations using continuum electrostatics were performed on the crystallographic structures of the isolated and bound proteins to gain structural insight for the on-rate enhancement observed at pH <6.5 and low salt concentrations. These calculations rule out electrostatic steering linked to global and/or local charge variations in the molecules as the factor responsible for the on-rate enhancement at low pH. His 111 of cAbLys3, located at the binding interface, can adopt two side chain orientations with different intramolecular contacts. The results of the calculations suggest an alternative mechanism whereby the conformation of the interfacial His 111 depends on the charge, and these differences in conformation may influence the solvation energy and the subsequent binding kinetics. Our results stress the complex relationship between environmental conditions and molecular binding properties.
Collapse
Affiliation(s)
- Annick Dejaegere
- UMR 7104, Structural Biology and Genomics Department, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, BP 10142 F-67404 Illkirch Cedex, France
| | | | | | | | | |
Collapse
|
38
|
Oliaro J, Dudal S, Liautard J, Andrault JB, Liautard JP, Lafont V. Vγ9Vδ2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella. J Leukoc Biol 2005; 77:652-60. [PMID: 15668339 DOI: 10.1189/jlb.0704433] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Human Vgamma9Vdelta2 T cells play a crucial role in early immune response to intracellular pathogens. In brucellosis infection, this population of cells is drastically increased in the peripheral blood of patients during the acute phase of infection. In vitro, Vgamma9Vdelta2 T cells exhibit strong cytolytic activity against Brucella-infected cells and are able to impair intracellular growth of Brucella suis in autologous macrophages. In this study, we have investigated the relative importance of contact-dependent mechanisms versus soluble factors in the intracellular growth and viability of B. suis. We show that Vgamma9Vdelta2 T cells use contact-dependent mechanisms, such as the release of lytic granules and Fas-mediated signals, to decrease intracellular B. suis through lysis of infected macrophages, but these mechanisms have little impact on Brucella survival. Moreover, we demonstrate that soluble factors secreted by Vgamma9Vdelta2 T cells can directly affect B. suis survival through their potent bactericidal effects. From these results, we conclude that Vgamma9Vdelta2 T cells are able to use a combination of mechanisms that reduce the total numbers of B. suis and thus, may benefit the host by limiting the spread of this intracellular pathogen.
Collapse
Affiliation(s)
- Jane Oliaro
- Institut National de la Santé et de la Recherche Médicale Unité 431, Microbiologie et Pathologie Cellulaire Infectieuse, Université de Montpellier II, Place Eugene Bataillon, CC 100, 34095 Montpellier Cedex 05, France
| | | | | | | | | | | |
Collapse
|
39
|
Dornand J, Lafont V, Oliaro J, Terraza A, Castaneda-Roldan E, Liautard JP. Impairment of intramacrophagic Brucella suis multiplication by human natural killer cells through a contact-dependent mechanism. Infect Immun 2004; 72:2303-11. [PMID: 15039355 PMCID: PMC375199 DOI: 10.1128/iai.72.4.2303-2311.2004] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Brucella spp. are facultative intracellular bacteria that can establish themselves and cause chronic disease in humans and animals. NK cells play a key role in host defense. They are implicated in an early immune response to a variety of pathogens. However, it was shown that they do not control Brucella infection in mice. On the other hand, NK cell activity is impaired in patients with acute brucellosis, and recently it was demonstrated that human NK cells mediate the killing of intramacrophagic Mycobacterium tuberculosis in in vitro infection. Therefore, we have analyzed the behavior of Brucella suis infecting isolated human macrophages in the presence of syngeneic NK cells. We show that (i) NK cells impair the intramacrophagic development of B. suis, a phenomenon enhanced by NK cell activators, such as interleukin-2; (ii) NK cells cultured in the presence of infected macrophages are highly activated and secrete gamma interferon and tumor necrosis factor alpha; (iii) impairment of bacterial multiplication inside infected cells is marginally associated with the cytokines produced during the early phase of macrophage-NK cell cocultures; (iv) direct cell-to-cell contact is required for NK cells to mediate the inhibition of B. suis development; and (v) inhibition of B. suis development results from an induction of NK cell cytotoxicity against infected macrophages. Altogether, these findings show that NK cells could participate early in controlling the intramacrophagic development of B. suis in humans. It seems thus reasonable to hypothesize a role for NK cells in the control of human brucellosis. However, by impairing the activity of these cells in the acute phase of the illness, the pathogen should avoid this control.
Collapse
Affiliation(s)
- Jacques Dornand
- INSERM U431, Université de Montpellier 2, 34095 Montpellier, France.
| | | | | | | | | | | |
Collapse
|
40
|
Lafont V, Loisel S, Liautard J, Dudal S, Sablé-Teychené M, Liautard JP, Favero J. Specific Signaling Pathways Triggered by IL-2 in Human Vγ9Vδ2 T Cells: An Amalgamation of NK and αβ T Cell Signaling. J Immunol 2003; 171:5225-32. [PMID: 14607923 DOI: 10.4049/jimmunol.171.10.5225] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The global immune response can be simplified into two components: the innate and the acquired systems. The innate immune response comprises primarily macrophages and NK cells, while B and T cells orchestrate the acquired response. Human Vgamma9Vdelta2 T cells represent a minor T cell subpopulation in blood (1-5%) that is activated via the TCR by small nonpeptidic molecules. Their percentage dramatically increases during the early phase of infection by intracellular pathogens, and they display many characteristics of NK cells, which places them at a unique position within the immune system. Our aim was to explore the behavior of these cells when they are activated by a receptor that is common to NK and alphabeta T cells, and to determine signaling pathways and biological responses induced in these cells through this receptor. Thus, we investigated whether Vgamma9Vdelta2 T cells behave as NK cells or as alphabeta T cells. We demonstrated that IL-2 activates not only STAT3, STAT5, the phosphatidylinositol 3-kinase pathway, and extracellular signal-regulated kinase-2 pathway, but also STAT4 as in NK cells, and the p38 mitogen-activated protein kinase pathway as in alphabeta T cells. Moreover, IL-2 induces the production of IFN-gamma in Vgamma9Vdelta2 T cells as observed in NK cells. Due to their double profiles, Vgamma9Vdelta2 T cells are at the interface of the innate and the acquired immune response and may therefore not only modulate the activity of innate cells, but also influence Th1/Th2 differentiation.
Collapse
MESH Headings
- Cells, Cultured
- DNA-Binding Proteins/metabolism
- Enzyme Activation/immunology
- Humans
- Interferon-gamma/biosynthesis
- Interleukin-2/physiology
- Janus Kinase 2
- Killer Cells, Natural/enzymology
- Killer Cells, Natural/immunology
- Killer Cells, Natural/metabolism
- Phosphorylation
- Protein Binding/immunology
- Protein-Tyrosine Kinases/metabolism
- Proteins/metabolism
- Proto-Oncogene Proteins
- Receptors, Antigen, T-Cell, alpha-beta/physiology
- Receptors, Antigen, T-Cell, gamma-delta/biosynthesis
- Receptors, Interleukin-2/biosynthesis
- Recombinant Proteins/pharmacology
- STAT4 Transcription Factor
- Signal Transduction/immunology
- T-Lymphocyte Subsets/enzymology
- T-Lymphocyte Subsets/immunology
- T-Lymphocyte Subsets/metabolism
- TYK2 Kinase
- Trans-Activators/metabolism
Collapse
Affiliation(s)
- Virginie Lafont
- Institut National de la Santé et de la Recherche Médicale Unité 431, Université Montpellier 2, Montpellier, France.
| | | | | | | | | | | | | |
Collapse
|
41
|
Abstract
A mutational analysis of three co-variant pairs of residues, located at the surface of a single-chain fragment, variable (scFv), remote from the antigen-binding site, was performed to investigate the tolerance of these positions to amino acid changes. The replacements consisted of the elimination or addition of charges, or in their replacement by a charge of opposite sign. As measured by Biacore, antigen-binding kinetics and specificity were essentially unaffected by the mutations. The purified scFvs remained mostly 100% active for 14 h, and their sensitivity to guanidinium-chloride denaturation was similar. These observations indicate that the mutations did not affect antigen-binding properties and that protein folding was conserved. However, the various scFvs differed greatly in half-life in periplasmic extracts (<4 h to >16 h at 25 degrees C). The deleterious effect on half-life produced by single mutations could be reversed by introducing a second mutation that restores the natural combination of amino acids in the co-variant pair, indicating that the consequence of charge modifications at these locations depends on the sequence context. We propose that the differences in half-life result from differences in aggregation propensities with other periplasmic proteins, related to the presence of charged patches at the surface of the scFvs. The practical implication is that changes in surface charge may drastically affect the level of active molecules in complex protein mixtures, a potentially important consideration in engineering scFvs for biotechnological or medical purposes.
Collapse
Affiliation(s)
- Nicolas Hugo
- Biotechnologie des Interactions Moléculaires Ecole Supérieure de Biotechnologie de Strasbourg, Pôle API, Bld Sébastien Brant, 67400 Illkirch, France
| | | | | | | |
Collapse
|
42
|
Lafont V, Liautard J, Liautard JP, Favero J. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen. J Immunol 2001; 166:7190-9. [PMID: 11390467 DOI: 10.4049/jimmunol.166.12.7190] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Human lymphocytes expressing the gammadelta TCR represent a minor T cell subpopulation found in blood. The majority of these cells express Vgamma9Vdelta2 determinants and respond to nonpeptidic phosphoantigens. Several studies have shown that, in vivo, the percentage of Vgamma9Vdelta2 T cells dramatically increases during pathological infection, leading to the hypothesis that they play an important role in the defense against pathogens. However, the specific mechanisms involved in this response remain poorly understood. It has been established that Vgamma9Vdelta2 T cells display potent cytotoxic activity against virus-infected and tumor cells, thereby resembling NK cells. In this study, we show that, upon stimulation by nonpeptidic Ags, Vgamma9Vdelta2 T cells express FcgammaRIIIA (CD16), a receptor that is constitutively expressed on NK cells. CD16 appears to be an activation Ag for Vgamma9Vdelta2 T cells. Indeed, ligation of CD16 on Vgamma9Vdelta2 T cells leads to TNF-alpha production. This TNF-alpha production, which is dependent (like that induced via the TCR-CD3 complex) on the activation of the p38 and extracellular signal-regulated kinase-2 mitogen-activated protein kinases, can be modulated by CD94 NK receptors. Therefore, it appears that Vgamma9Vdelta2 T cells can be physiologically activated by two sequential steps via two different cell surface Ags: the TCR-CD3 complex and the FcgammaRIIIA receptor, which are specific cell surface Ags for T lymphocytes and NK cells, respectively. This strongly suggests that, in the general scheme of the immune response, Vgamma9Vdelta2 T cells represent an important subpopulation of cells that play a key role in the defense against invading pathogens.
Collapse
MESH Headings
- Antibodies, Monoclonal/pharmacology
- Antigens, Bacterial/immunology
- Antigens, CD/immunology
- Antigens, CD/metabolism
- Cells, Cultured
- Down-Regulation/immunology
- Hemiterpenes
- Humans
- Immune Sera/pharmacology
- Immunoglobulin Fc Fragments/metabolism
- Immunoglobulin G/metabolism
- Immunoglobulin G/physiology
- Lectins, C-Type
- Lymphocyte Activation/immunology
- MAP Kinase Kinase 2
- MAP Kinase Signaling System/immunology
- Membrane Glycoproteins/immunology
- Membrane Glycoproteins/metabolism
- Mitogen-Activated Protein Kinase Kinases/metabolism
- Mitogen-Activated Protein Kinases/metabolism
- NK Cell Lectin-Like Receptor Subfamily D
- Organophosphorus Compounds/immunology
- Phosphorylation
- Protein-Tyrosine Kinases/metabolism
- Receptor-CD3 Complex, Antigen, T-Cell/antagonists & inhibitors
- Receptor-CD3 Complex, Antigen, T-Cell/immunology
- Receptor-CD3 Complex, Antigen, T-Cell/metabolism
- Receptors, Antigen, T-Cell, gamma-delta/biosynthesis
- Receptors, Antigen, T-Cell, gamma-delta/metabolism
- Receptors, IgG/biosynthesis
- Receptors, IgG/immunology
- Receptors, IgG/metabolism
- Receptors, IgG/physiology
- T-Lymphocyte Subsets/enzymology
- T-Lymphocyte Subsets/immunology
- T-Lymphocyte Subsets/metabolism
- Time Factors
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
- Tumor Necrosis Factor-alpha/biosynthesis
- Tyrosine/metabolism
- p38 Mitogen-Activated Protein Kinases
Collapse
Affiliation(s)
- V Lafont
- Institut National de la Santé et de la Recherche Médicale, Unité 431, Microbiologie et Pathologie Cellulaire Infectieuse, Université Montpellier II, Montpellier, France.
| | | | | | | |
Collapse
|
43
|
Lafont V, Liautard J, Sable-Teychene M, Sainte-Marie Y, Favero J. Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human gamma delta T lymphocytes without inducing eown-modulation of T cell antigen receptor. J Biol Chem 2001; 276:15961-7. [PMID: 11278429 DOI: 10.1074/jbc.m008684200] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The Vgamma9Vdelta2 T cell subset, which represents up to 90% of the circulating gammadelta T cells in humans, was shown to be activated, via the T cell receptor (TcR), by non-peptidic phosphorylated small organic molecules. These phosphoantigens, which are not presented by professional antigen-presenting cells, induce production of high amounts of interferon-gamma and tumor necrosis factor (TNF-alpha). To date, the specific signals triggered by these antigens have not been characterized. Here we analyze proximal and later intracellular signals triggered by isopentenyl pyrophosphate (IPP), a mycobacterial antigen that specifically stimulates Vgamma9Vdelta2 T cells, and compare these to signals induced by the non-physiological model using an anti-CD3 antibody. During antigenic stimulation we noticed that, except for the proximal p56(lck) signal, which is triggered early, the signals appear to be delayed and highly sustained. This delay, which likely accounts for the delay observed in TNF-alpha production, is discussed in terms of the ability of the antigen to cross-link and recruit transducing molecules mostly anchored to lipid rafts. Moreover, we demonstrate that, in contrast to anti-CD3 antibody, IPP does not induce down-modulation of the TcR.CD3 complex, which likely results in the highly sustained signaling and release of high levels of TNF-alpha.
Collapse
MESH Headings
- Antigens, Bacterial/pharmacology
- Cells, Cultured
- Down-Regulation/drug effects
- Hemiterpenes
- Humans
- Kinetics
- Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism
- Mitogen-Activated Protein Kinase 1/metabolism
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinases/metabolism
- Mycobacterium/immunology
- Organophosphorus Compounds/pharmacology
- Phosphorylation
- Protein-Tyrosine Kinases/metabolism
- Receptors, Antigen, T-Cell/drug effects
- Receptors, Antigen, T-Cell/immunology
- Receptors, Antigen, T-Cell, gamma-delta/drug effects
- Receptors, Antigen, T-Cell, gamma-delta/immunology
- Signal Transduction/drug effects
- Signal Transduction/immunology
- T-Lymphocytes/drug effects
- T-Lymphocytes/immunology
- Tumor Necrosis Factor-alpha/biosynthesis
- ZAP-70 Protein-Tyrosine Kinase
Collapse
Affiliation(s)
- V Lafont
- INSERM U431, Microbiologie et Pathologie Cellulaire Infectieuse, Université Montpellier 2, Place Eugène Bataillon, cc 100, Montpellier 34095, cedex 5, France
| | | | | | | | | |
Collapse
|
44
|
Lafont V, Astoul E, Laurence A, Liautard J, Cantrell D. The T cell antigen receptor activates phosphatidylinositol 3-kinase-regulated serine kinases protein kinase B and ribosomal S6 kinase 1. FEBS Lett 2000; 486:38-42. [PMID: 11108839 DOI: 10.1016/s0014-5793(00)02235-3] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The present study has explored T cell antigen receptor-regulated serine kinases in human T cells. The results identify two phosphatidylinositol 3-kinase (PI3K)-controlled serine kinases operating downstream of the T cell receptor (TCR) in primary T cells: (i) protein kinase B whose activation regulates the phosphorylation of glycogen synthase kinase 3 and (ii) ribosomal S6 kinase 1, a kinase with a critical role in the regulation of protein synthesis and cell growth. T cells express two isoforms of S6k1: a 70 kDa cytoplasmic kinase and an 85 kDa isoform that has a classic nuclear localisation. TCR ligation triggers a parallel engagement of both the 70 and 85 kDa isoforms of S6k1 in a response that requires PI3K function.
Collapse
Affiliation(s)
- V Lafont
- Lymphocyte Activation Laboratory, Imperial Cancer Research Fund, London, UK.
| | | | | | | | | |
Collapse
|
45
|
Abstract
A nonrestrictive method for identifying covariance in protein families is described and applied to human and mouse germline Vkappa and VH sequence alignments. Amino acids that occur at each position in a sequence alignment are divided into two sets, called a word, by generating all possible combinations of alternative amino acids. Each word is associated with a pattern of changes. Words with identical patterns identify covariant positions. In antibody variable domains, the number of words generated ranged between 1103 and 2195 depending on the alignment, of which 4 to 12 % occurred in covariant pairs. Despite the nonrestrictive character of pattern generation, covariant residues did not reflect a random selection with respect to the nature of amino acid changes and/or their spatial proximity in a reference crystallographic structure. This approach allowed the identification of a covariance signal for positions with high variability, mostly located in the outer part of the common structural framework of antibody variable domains. Covariance in these regions may reflect the existence of alternative and mutually exclusive atomic arrangements that are compatible with antibody function. The method may be of general applicability to rationalize residue variability in protein families.
Collapse
Affiliation(s)
- L Choulier
- UPR 9021-CNRS, Institut de Biologie Moléculaire et Cellulaire, Strasbourg Cedex, France
| | | | | | | |
Collapse
|
46
|
Gokalsing E, Robert PH, Lafont V, Medecin I, Baudu C, Boyer P, Pringuey D, Darcourt G. Evaluation of the supervisory system in elderly subjects with and without disinhibition. Eur Psychiatry 2000; 15:407-15. [PMID: 11112933 DOI: 10.1016/s0924-9338(00)00511-3] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
UNLABELLED Disinhibition and irritability, defined as loss of behavioral and emotional control, are frequent in the elderly. The working hypothesis for this study was that these disorders are associated with a cognitive alteration of control processes that manifests as non-routine behavior because of the dysfunction of a general executive component known as the supervisory attentional system (SAS). METHODS A total of 28 elderly subjects with mild cognitive impairment were recruited and divided into two groups using the Neuropsychiatric Inventory. Fourteen subjects were allocated to the disinhibited group and 14 subjects matched for age, sex and educational level formed a disinhibition-free control group. The neuropsychological battery included the following tests: Mini Mental Score Evaluation, Boston Naming test, Token test, Trail Making and Verbal Fluency. Two tasks were specifically designed to stress the SAS: 1) A specific verbal sentence arrangement task in which subjects had to use sequential reasoning with verbal material. Each test sequence consisted of a series of words shown in jumbled order. The construction of some sequences had to be done by using familiar routine associations (valid conditions). In contrast, other sequences required the overriding selection of familiar routine associations, which were inappropriate within the general context of the task (invalid conditions). 2) Using the Continuous Performance Test, four aspects were evaluated: sustained, selective, preparation and suppressive attention. RESULTS The only group differences in neuropsychological test results were the following: 1) the sentence arrangement task. In comparison with the control group, the disinhibited group was impaired in invalid conditions and the calculated difference between the number of correct responses in invalid conditions minus that in valid conditions was significantly higher; and 2) the CPT. Disinhibited subjects had a significantly lower number of hits, exclusively in the 'suppressive attention' paradigm. These results suggest that subjects with disinhibition have impaired supervisory system function.
Collapse
Affiliation(s)
- E Gokalsing
- Memory Center, Department of Psychiatry, University of Nice Sophia Antipolis, Nice, France
| | | | | | | | | | | | | | | |
Collapse
|
47
|
Abstract
Antigen receptors are crucial regulators of the mammalian immune response. Immediate antigen receptor proximal signal transduction pathways mediated by tyrosine (Tyr) kinases are well defined. In contrast, much less is known about the network of serine (Ser) kinases and Ser kinase substrates that are linked to antigen receptor function. Here we describe a new signaling module for antigen receptors in lymphocytes; a Ser kinase pathway that phosphorylates Ser 727 in STAT1alpha, a member of the signal transducer and activator of transcription gene family. In the present study we have explored the regulation of STAT1 Ser 727 phosphorylation in human T and B lymphocytes and show that it is controlled by both positive and negative antigen receptor signaling cascades. Ligation of antigen receptors in both B and T cells induce a delayed but then sustained phosphorylation of STAT1 on Ser 727. STAT1 Ser phosphorylation is induced by the TCR in the absence of STAT1 Tyr phosphorylation, indicating that in T cells STAT1 Ser and Tyr phosphorylation are independent events. Antigen receptor regulation of STAT Ser phosphorylation is dependent on phosphatidylinositol 3-kinase-mediated signals. Furthermore, the negative regulatory receptor FcgammaRIIb, which mediates vital feedback control of B cell responses, prevents antigen receptor-induced phosphorylation of STAT1 Ser 727. The ability of antigen receptors to both positively and negatively regulate STAT1 Ser 727 phosphorylation reveals a Ser kinase network that operated during sustained responses to antigen receptor engagement.
Collapse
Affiliation(s)
- V Lafont
- Vienna Biocenter, Institute of Microbiology and Genetics, Austria
| | | | | |
Collapse
|
48
|
Lafont V, Liautard J, Gross A, Liautard JP, Favero J. Tumor necrosis factor-alpha production is differently regulated in gamma delta and alpha beta human T lymphocytes. J Biol Chem 2000; 275:19282-7. [PMID: 10764820 DOI: 10.1074/jbc.m910487199] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in the early defense against pathogens. This cytokine is produced by several cell types including T lymphocytes expressing the alphabeta as well as the gammadelta T cell receptor (TcR). In human, the circulating gammadelta T cells, which mostly express Vgamma9Vdelta2 TcR, have been strongly suggested to play an important protective role against infectious agents. These activated cells early produce high amounts of TNF-alpha, which induce a determinant beneficial effect against development of intracellular pathogens; however, sustained production of this cytokine can result in immunopathological diseases. The signals that regulate TNF-alpha production in Vgamma9Vdelta2 T cells are totally unknown. In primary alphabeta T cells, TNF-alpha production was shown to necessitate engagement of the TcR and CD28, and to be independent of the p38 mitogen activated protein kinase pathway. We demonstrate herein that, in contrast to alphabeta T cells, TNF-alpha production in Vgamma9Vdelta2 T lymphocytes is independent of CD28 costimulation and highly dependent on TcR-induced p38 kinase and extracellular signal-regulated kinase 2 pathway activation for optimal cytokine release. Moreover, we bring elements supporting the idea that the "activation threshold" of gammadelta T cells leading to cytokine production is lower than that of alphabeta T cells.
Collapse
Affiliation(s)
- V Lafont
- INSERM U431, Microbiologie et Pathologie Cellulaire Infectieuse, Université Montpellier 2, Place Eugène Bataillon, cc 100, 34095 Montpellier cedex 05, France
| | | | | | | | | |
Collapse
|
49
|
Robert PH, Lafont V, Snowden JS, Lebert F. [Diagnostic criteria for fronto-temporal lobe degeneration]. Encephale 1999; 25:612-21. [PMID: 10668605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
Circumscribed atrophy of the frontal and temporal lobes (frontotemporal lobar degeneration) accounts for about one fifth of cases of primary degenerative dementia occurring before the age of 65. It produces three prototypical clinical syndromes. The most common is frontotemporal dementia, characterized by personality change and profound alteration in social conduct and associated with bilateral atrophy of the frontal and anterior temporal lobes. Progressive non-fluent aphasia is characterized by difficulty in verbal expression, anomia and phonemic errors in the presence of relative preservation of comprehension and associated with atrophy predominantly of the left hemisphere. In semantic dementia there is fluent speech with semantic errors and severely impaired comprehension and naming, together with a visual associative agnosia, resulting from bilateral atrophy of the inferior and middle temporal gyri. The clinical syndromes occur with either of two main histological types: prominent microvacuolar change, without specific histological features (frontal lobe degeneration-type), severe astrocytic gliosis with or without ballooned cells and inclusion bodies (Pick-type). To improve clinical recognition and advance understanding of this relatively common form of cerebral degeneration, members of an international workshop on Frontotemporal Lobar Degeneration developed consensus criteria, building upon earlier published clinical diagnostic guidelines for frontotemporal dementia. The consensus criteria reported here specify core and supportive features for each of the prototypical clinical syndromes: frontotemporal dementia, progressive aphasia and semantic dementia, as well as providing broad inclusion and exclusion criteria for the generic entity of frontotemporal lobar degeneration.
Collapse
|
50
|
Lafont V, Ottones F, Liautard J, Favero J. Evidence for a p21(ras)/Raf-1/MEK-1/ERK-2-independent pathway in stimulation of IL-2 gene transcription in human primary T lymphocytes. J Biol Chem 1999; 274:25743-8. [PMID: 10464312 DOI: 10.1074/jbc.274.36.25743] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
T cell stimulation leads to triggering of signals transmitted from the cell membrane to the nucleus through TCR/CD3 proteins. Characterization of these signals largely results from the use of cell lines stimulated with anti-CD3 monoclonal antibodies. These studies have established that activation caused a rapid increase in the formation of GTP-bound Ras, which stimulates the mitogen-activated protein kinase pathway involving the extracellular-regulated kinase-2 (ERK-2) and activates the nuclear factor of activated T cells (NF-AT) that regulates interleukin-2 (IL-2) gene transcription. In the present study, we used human primary T cells, and we investigated the intracellular signals triggered by two different anti-CD3 monoclonal antibodies (UCHT1 and X-35), which both strongly induce cell proliferation. We found that, in contrast to the commonly used UCHT1, X-35 activated IL-2 gene transcription without stimulation of the Raf-1/mitogen-activated ERK kinase-1 (MEK-1)/ERK-2 phosphorylation cascade; we also showed that X-35 stimulation, which triggers an ERK-2-independent pathway, does not involve activation of p21(ras). In addition to demonstrating that activation of p21(ras) and of its Raf-1/MEK-1/ERK-2 effector pathway is not an event obligatorily triggered upon TCR/CD3 ligation, these results provide the first evidence of the existence of a p21(ras)/ERK-2-independent pathway for IL-2 gene transcription in human primary T lymphocytes.
Collapse
Affiliation(s)
- V Lafont
- Lymphocyte Activation Laboratory, Imperial Cancer Research Fund, London, United Kingdom WC2A 3PX
| | | | | | | |
Collapse
|